Document:

EX-10.58

Exhibit 10.58

CONFORMED COPY

AMENDMENT NO. 1

TO THE WEBMD, LLC SUPPLEMENTAL BONUS PROGRAM

TRUST AGREEMENT

          THIS AMENDMENT is made to be effective as of March 30, 2009:

          WHEREAS, WebMD, LLC (the “Company”), a wholly-owned subsidiary of WebMD Health Corp., and
Peter Anevski (the “Trustee”) are parties to the WebMD, LLC Supplemental Bonus Program Trust
Agreement (as Amended and Restated Effective as of March 15, 2008) (the “Trust Agreement”);

          WHEREAS, due to organizational changes, the Company is being changed from WebMD, LLC to WebMD
Health Corp.;

          WHEREAS, for the supplemental bonus program for 2008, Section 3.02(b) is being amended; and

          WHEREAS, the Governing Committee has been delegated the right to amend the Trust Agreement on
behalf of the Company from time to time.

          NOW, THEREFORE, the Trust Agreement is hereby amended as follows:

1.

          All references to “WebMD, LLC” shall be changed and deemed to refer to “WebMD Health Corp.”
(unless the applicable context clearly requires otherwise). Further, all references to “WebMD, LLC
Supplemental Bonus Program Trust Agreement” shall be changed and deemed to refer to “WebMD Health
Corp. Supplemental Bonus Program Trust Agreement”.

2.

          Section 3.02(b) of the Trust Agreement is hereby amended in its entirety to read as follows:

          “(b) Upon a Participant’s Termination of Employment prior to the Participant Bonus
Determination Date, he or she shall forfeit all rights to any portion of his or her Bonus; provided
however that if a Participant (i) dies or (ii) the Administrative Committee determines that a
Participant’s Termination of Employment is (A) a result of a Disability or (B) a result of the sale
of the Subsidiary or Division by which he or she is employed, then such Participant shall be
entitled to his or her Bonus, which shall be paid within 2-1/2 months following the date of his or
her Termination of Employment. In

1

 

addition, in the event of a Participant’s Termination of Employment as part of a reduction in force
or due to the elimination of the Participant’s position, the Governing Committee shall have the
authority, in its discretion, to determine that the Bonus will not be forfeited, in which case, the
Participant shall be entitled to his or her Bonus, which shall be paid within 2-1/2 months
following the date of his or her Termination of Employment. The amount of any Bonus payable under
this Section 3.02(b) shall be the amount set forth on the 2007 Participant List, and will not be
adjusted to reflect any reallocation of amounts credited to the Income Expense Account or the
Forfeiture Account.”

3.

          Except as provided herein, the provisions of the Trust Agreement shall remain in full force
and effect.

          IN WITNESS WHEREOF, each of the undersigned has duly executed this Amendment to be effective
as of the day and year first written above.

	 	 	 	 	 	 	 
	TRUSTEE

	 	 	 	GOVERNING COMMITTEE	 	 
	 
	 	 	 	 	 	 
	     /s/ Peter Anevski
 

Peter Anevski

	 	 	 	     /s/ Wayne Gattinella
 

Wayne Gattinella
	 	 
	 
	 	 	 	 	 	 
	 

	 	 	 	     /s/ Anthony Vuolo
 

Anthony Vuolo
	 	 

2EX-10.59

Exhibit 10.59

CONFORMED COPY

WebMD Health Corp.

111 Eighth Avenue

New York, NY 10001

October 1, 2007

William E. Pence

[Address]

Dear Mr. Pence:

          This letter confirms the terms of your employment with WebMD Health Corp. (the “Company” or
“WebMD Health”), a subsidiary of HLTH Corporation.

          1. Position and Responsibilities. The first day of your employment with the Company
shall be on or about October 22, 2007 (the actual start date, which is not expected to be later
than November 5, 2007, shall be referred to as the “Employment Commencement Date”). You
will serve in the position of Executive Vice President and Chief Technology Officer. You will
report to the Chief Executive Officer, President or Chief Operating Officer of WebMD Health and
will assume and discharge such responsibilities as are commensurate with such position as such
person may direct. During your employment with the Company, you will devote your full business
time to your duties and responsibilities and will perform them faithfully and diligently in
accordance with the terms of this Agreement, subject to permitted absence in accordance with the
Company’s vacation policy. In addition, you will comply with and be bound by the operating
policies, procedures and practices of the Company including, without limitation, the Code of
Conduct, in effect from time to time during your employment. You will report to the Company’s
headquarters located in New York, NY. You acknowledge that you will be required to travel in
connection with the performance of your duties but you will not be required to relocate outside the
New York metropolitan area without your consent.

          2. Compensation.

          (a) In consideration of your services, you will be paid a base salary (“Base Salary”) at the
annual rate of $375,000, payable in accordance with the Company’s prevailing payroll practices.

          (b) You will be eligible to receive an annual bonus, the target of which is 35% of Base
Salary, so long as you are employed by the Company on the applicable payment date, except as set
forth below. The determination as to the amount of such bonus shall be made by the WebMD Health
Compensation Committee in its sole discretion. For calendar year 2007, you will be guaranteed an
annual bonus payment of $75,000, which shall be paid at such time as

 

executive officer bonuses are paid generally, so long as you remain in the employ of the
Company on such payment date. Subject to Section 5 below, if your employment is terminated
following the end of any fiscal year by the Company without Cause or by you for Good Reason (as
defined below), then you will still be entitled to receive any bonus otherwise payable to you for
such year, even if you are not employed on the bonus payment date and such bonus will be paid at
the time that bonuses are paid to other executives of the Company.

          3. Other Benefits. You will continue to be entitled to receive the standard employee
benefits made available by the Company to its employees to the full extent of your eligibility.
You will be entitled to vacation consistent with the Company’s vacation policy, but in no event
less than 4 weeks annually (pro-rated for 2007). During your employment, you will be permitted, to
the extent eligible, to participate in any group medical, dental, life insurance and disability
insurance plans, or similar benefit plan of the Company that is available to employees generally.
Participation in any such plan will be consistent with your rate of compensation to the extent that
compensation is a determinative factor with respect to coverage under any such plan. The Company
will reimburse you for all reasonable expenses actually incurred or paid by you in the performance
of your services on behalf of the Company, upon prior authorization and approval in accordance with
the Company’s expense reimbursement policy as from time to time in effect.

          4. WebMD Health Equity.

          (a) Options. On the Employment Commencement Date, Executive shall be granted a
nonqualified option (the “Option”) to purchase 150,000 shares of common stock of WebMD
Health Corp. under the WebMD Health Corp. 2005 Long Term Incentive Plan, as amended, (the “Equity
Plan”). The per share exercise price shall be the closing price of the common stock on the
Employment Commencement Date and the Option shall vest, subject to Executive’s continued employment
on the applicable vesting dates (except as set forth in Section 5), in four equal annual
installments of 25% on each of the first anniversary of the Employment Commencement Date, the
second anniversary; the third anniversary and the fourth anniversary of the Employment Commencement
Date. The Option will be granted pursuant to the terms of a stock option plan and a stock option
agreement to be entered into between you and the Company, which agreement will be in substantially
the same form provided by the Company to its employees generally.

          (b) Restricted Stock. On the Employment Commencement Date, Executive shall be granted
25,000 shares of restricted stock of WebMD Health Corp. (the “Restricted Stock”) under the Equity
Plan. The Restricted Stock shall vest and the restrictions thereon lapse in the same percentage
and at the same times as described above with respect to the Option, subject to Executive’s
continued employment on the applicable vesting dates (except as set forth in Section 5). The
Restricted Stock will be subject to the terms of a stock plan and a restricted stock agreement to
be entered into between you and the Company, which agreement will be in substantially the same form
provided by the Company to its employees generally.

          5. Termination of Employment. In the event of the termination of your employment by
the Company without Cause or by you for Good Reason (as such terms are defined on Annex

2

 

A attached hereto)
prior to the fourth anniversary of the Employment Commencement
Date, you will be entitled to (i) continue to receive, as severance, the Base Salary in effect on
the date hereof for a period of one year (the “Severance Period”), (ii) any bonus payable under the
last sentence in Section 2(b) above, and (iii) if you timely elect to continue your health coverage
through COBRA, the Company will pay that portion of the COBRA premium that it would pay if you were
an active employee with the same type of coverage through the Severance Period or, if earlier,
until you are eligible for comparable coverage with a subsequent employer, subject to your
execution of a release satisfactory to the Company (but which will not require release of any
Company payments due to you that are otherwise payable at the date of termination of this
Agreement) and your continued compliance with the Trade Secret & Proprietary Information Agreement.
In addition, in the event of the termination of your employment by the Company without Cause or by
you for Good Reason prior to the fourth anniversary of the Employment Commencement Date, 25% of the
Option will continue to vest and remain outstanding as if you remained in the employ of the Company
through the vesting date following the date of termination; provided however, that in the event of
the termination of your employment by the Company without Cause or by you for Good Reason within 12
months following a Change of Control of the Company (as defined in the Equity Plan), (i) the Option
will continue to vest and remain outstanding as if you remained in the employ of the Company
through the second vesting date following the date of termination and (ii) 25% of the Restricted
Stock will continue to vest as if you remained in the employ of the Company through the next
vesting date following the date of such a termination; and provided further that such continued
vesting is subject to your execution of a release satisfactory to the Company and your continued
compliance with the Trade Secret & Proprietary Information Agreement. In the event of termination
of your employment for any other reason, you will receive compensation earned through the date of
termination and your rights with respect to options and restricted stock will be as specified in
the applicable option or restricted stock agreements.

          6. Section 409A. Any payments required to be paid to you pursuant to this Agreement
during the first six months following the termination of your employment, including without
limitation the severance payments provided for in Section 5 above, shall be paid to you in a lump
sum at the end of such six-month period in accordance with the requirements of Section 409A of the
Internal Revenue Code of 1986, as amended (“Section 409A”), provided that such delay in
payments will not apply to the extent that guidance issued under Section 409A allow payments to be
made when otherwise due without subjecting you to additional taxes under Section 409A.

          7. Restrictive Covenants. You agree that the effectiveness of this Agreement is
contingent upon your execution of, and delivery to the Company of Trade Secret & Proprietary
Information Agreement in the form attached hereto as Annex B.

          8. Conflicting Employment. You agree that, during your employment with the Company,
you will not engage in any other employment, occupation, consulting or other business activity
directly related to the business in which the Company is now involved or becomes involved during
your employment, nor will you engage in any other activities that conflict with your obligations to
the Company. With the prior written approval of the Company, which will not be unreasonably
withheld, you may serve on the Board of Directors of other

3

 

companies, and provided that such service does not affect the services to be provided under
this Agreement.

          9. At-Will Employment. You acknowledge that your employment with the Company is for an
unspecified duration that constitutes at-will employment, and that either you or the Company can
terminate this relationship at any time, with or without Cause and with or without notice (subject
to the consequences set forth in this agreement).

          10. Effective Date. This Agreement will become effective as of the Employment
Commencement Date.

          11. General Provisions.

	 	(a)	 	You will be covered by the Company’s director and officer insurance policy to
the same extent as other similarly situated employees of the Company.
	 
	 	(b)	 	This letter agreement and the terms of your employment will be governed by the
laws of New York, applicable to agreements made and to be performed entirely within
such state and the courts sitting in New York, New York shall have exclusive
jurisdiction for the purposes of adjudicating any disputes under this Agreement.
	 
	 	(c)	 	This letter agreement together with the equity plans and agreements referred to
herein and the Trade Secret and Proprietary Agreement attached hereto sets forth the
entire agreement and understanding between the Company and you relating to your
employment and supersedes all prior verbal discussions between us and the Prior
Agreements.
	 
	 	(d)	 	This agreement will be binding upon your heirs, executors, administrators and
other legal representatives and will be for the benefit of the Company and its
permitted successors and assigns
	 
	 	(e)	 	All payments pursuant to this letter will be subject to applicable withholding
taxes.
	 
	 	(f)	 	This agreement may not be assigned by the Company without your prior written
consent; provided however that this agreement may be assigned by the Company without
your prior written consent to any successor to the business of the Company, by
operation of law, merger or otherwise or to any affiliate of the Company.

4

 

          Please acknowledge and confirm your acceptance of this letter by, signing and returning one
copy of this letter agreement and the Trade Secret & Proprietary Information Agreement to Douglas
W. Wamsley, Executive Vice President, General Counsel, WebMD Health Corp., 111 Eighth Avenue, New
York, NY 10001.

	 	 	 	 	 
	WebMD Health Corp.	 	 
	 
	 	 	 	 
	By:

	 	     /s/ Douglas W. Wamsley
 

Douglas W. Wamsley

Executive Vice President, General Counsel
	 	 

ACCEPTANCE:

          I accept the revised terms of my employment with WebMD Health Corp. as set forth herein. I
understand that this letter agreement does not constitute a contract of employment for any
specified period of time, and that either party, with or without Cause and with or without notice,
may terminate my employment relationship (subject to the consequences set forth above).

	 	 	 
	     /s/ William E. Pence
 

William E. Pence

	 	 
	 
	 	 
	     October 1, 2007
 

Date Signed

	 	 

5

 

ANNEX A

“Cause” will mean any of the following:

          (i) your willful failure to perform your duties following written notice from the Company
detailing the specific acts and a thirty (30) day period of time to remedy such failure;

          (ii) any willful misconduct, violence or threat of violence that is injurious to the Company
in a material respect or any misconduct relating to your business affairs, at any time, which will
demonstrably reflect negatively upon the Company or otherwise impair or impede its operations or
reputation in any material respect;

          (iii) your breach of a material Company policy, which breach is not remedied (if susceptible
to remedy) following written notice by the Company detailing the specific breach and a thirty (30)
day period of time to remedy such breach;

          (iv) any material breach by you of this Agreement or the Trade Secret and Proprietary
Information Agreement, which breach is not remedied (if susceptible to remedy) following written
notice by the Company or its designee detailing the specific breach and a thirty (30) day period of
time to remedy such breach;

          (v) your conviction of a felony in respect of a dishonest or fraudulent act or other crime of
moral turpitude.

          “Good Reason” means any of the following conditions or events that remain in effect
30 days after written notice is provided by you to the Company detailing such condition or event
(i) any reduction in your base salary, (ii) a material reduction in your authority with the Company
and (iii) any material breach by the Company of this Agreement.

 

ANNEX B

TRADE SECRET AND PROPRIETARY INFORMATION AGREEMENT

          In consideration of WebMD Health Corp. (hereinafter referred to as the “Company”) entering
into the Letter Agreement dated October 1, 2007, I hereby agree as follows:

          1. Confidentiality.

               (a) Trade Secret and Proprietary Information. I understand and acknowledge that,
during the course of my employment arrangement with the Company and as a result of my having
executed this Trade Secret and Proprietary Information Agreement, I will be granted access to
valuable information relating to the Company’s Business (as defined below) that provides the
Company with a competitive advantage, which is not generally known by, nor easily learned or
determined by, persons outside the Company (collectively “Trade Secret an Proprietary
Information”). The term Trade Secret and Proprietary Information will include, but will not be
limited to: (a) specifications, manuals, software in various stages of development; (b) customer
and prospect lists, and details of agreements and communications with customers and prospects; (c)
sales plans and projections, product pricing information, acquisition, expansion, marketing,
financial and other business information and existing and future products and business plans of the
Company; (d) sales proposals, demonstrations systems, sales material; (e) research and development;
(f) computer programs, (g) sources of supply; (h) identity of specialized consultants and
contractors and Trade Secret and Proprietary Information developed by them for the Company; (i)
purchasing, operating and other cost data; (j) special customer needs, cost and pricing data; (k)
patient information; including without limitation Protected Health Information as defined in 45
C.F.R. 164.501 and (l) employee information (including, but not limited to, personnel, payroll,
compensation and benefit data and plans), including all such information recorded in manuals,
memoranda, projections, reports, minutes, plans, drawings, sketches, designs, formula books, data,
specifications, software programs and records, whether or not legended or otherwise identified by
the Company as Trade Secret and Proprietary Information, as well as such information that is the
subject of meetings and discussions and not recorded. Trade Secret and Proprietary Information
will not include such information that I can demonstrate (i) is generally available to the public
(other than as a result of a disclosure by me), (ii) was disclosed to me by a third party under no
obligation to keep such information confidential or (iii) was known by me prior to, and not as a
result of, my employment or anticipated employment with the Company or any of its Affiliates.

               (b) Duty of Confidentiality. I agree at all times, both during and after my employment
with the Company, to hold all of the Company’s Trade Secret and Proprietary Information in a
fiduciary capacity for the benefit of the Company and to safeguard all such Trade Secret and
Proprietary Information. I also agree that I will not directly or indirectly disclose or use any
such Trade Secret and Proprietary Information to any third person or entity outside the Company,
except as may be necessary in the good faith performance of my duties for the Company. I further
agree that, in addition to enforcing this restriction, the Company may have other rights and
remedies under the common law or applicable statutory laws relating to the protection of trade
secrets. Notwithstanding anything in this Agreement to the contrary, I

 

understand that I may disclose the Company’s Trade Secret and Proprietary Information to the
extent required by applicable laws or governmental regulations or judicial or regulatory process,
provided that I give the Company prompt notice of any and all such requests for disclosure so that
it has ample opportunity to take all necessary or desired action, to avoid disclosure.

          (c) Unfair Competition. I acknowledge that the Company has a compelling business
interest in preventing unfair competition stemming from the intentional or inadvertent use or
disclosure of the Company’s Trade Secret and Proprietary Information and Company Property.

          (d) Intellectual Property and Inventions. I acknowledge that all developments,
including, without limitation, the creation of new products, conferences, training/seminars,
publications, programs, methods of organizing information, inventions, discoveries, concepts,
ideas, improvements, patents, trademarks, trade names, copyrights, trade secrets, designs, works,
reports, computer software, flow charts, diagrams, procedures, data, documentation, and writings
and applications thereof relating to the past, present, or future business of the Company that I,
alone or jointly with others, may have discovered, conceived, created, made, developed, reduced to
practice, or acquired during my employment with the Company (collectively, “Developments”) are
works made for hire and will remain the sole and exclusive property of the Company, and I hereby
assign to the Company all of my rights, titles, and interest in and to all such Developments, if
any. I agree to disclose to the Company promptly and fully all future Developments and, at any time
upon request and at the expense of the Company, to execute, acknowledge, and deliver to the Company
all instruments that the Company will prepare, to give evidence, and to take any and all other
actions that are necessary or desirable in the reasonable opinion of the Company to enable the
Company to file and prosecute applications for, and to acquire, maintain, and enforce, all letters
patent, trademark registrations, or copyrights covering the Developments in all countries in which
the same are deemed necessary by the Company. All data, memoranda, notes, lists, drawings,
records, files, investor and client/customer lists, supplier lists, and other documentation (and
all copies thereof) made or compiled by me or made available to me concerning the Developments or
otherwise concerning the past, present, or planned business of the Company are the property of the
Company, and will be delivered to the Company immediately upon the termination of my employment
with the Company.

          (e) Competitive Business. For purposes of this Agreement “Competitive Business” will
mean: (i) any enterprise engaged in developing, selling or providing a consumer or physician
Internet healthcare portal or interactive online personal health management products; and (ii) any
enterprise engaged in any other type of business in which the Company or one of its Affiliates is
also engaged, or plans to be engaged, so long as I am directly involved in such business or planned
business on behalf of the Company or one of its Affiliates.

          2. Non-Solicitation of Employees, Customers. In order to protect the Company’s Trade
Secret and Proprietary Information;

          (i) during my employment with the Company and for a period of one year after the termination
of such employment for any reason (the “Restricted Period”), I will not, without the Company’s
express written permission, directly or indirectly solicit, induce, hire, engage, or attempt to
hire or engage any employee or independent contractor of the Company, or in any other way interfere
with the Company’s employment or contractual relations with any of its

2

 

employees or independent contractors, nor will I solicit, induce, hire, engage or attempt to
hire or engage any individual who was an employee of the Company at any time during the one year
period immediately prior to the termination of my employment with the Company

          (ii) during the Restricted Period, I will not, without the Company’s express written
permission, directly or indirectly contact, call upon or solicit, on behalf of a Competitive
Business, any existing or prospective client, or customer of the Company who I serviced, or
otherwise developed a relationship with, as a result of my employment with the Company, nor will I
attempt to divert or take away from the Company the business of any such client or customer.

          3. Restrictions on Competitive Employment. In order to protect the Company’s Trade
Secret and Proprietary Information, during the Restricted Period, I will not (as principal, agent,
employee, consultant, director or otherwise), anywhere in the United States and Canada, directly or
indirectly, without the prior written approval of the Company, engage in, or perform any services
for, a Competitive Business. Notwithstanding the foregoing, I understand that I may have an
interest consisting of publicly traded securities constituting less than 1 percent of any class of
publicly traded securities in any public company engaged in a Competitive Business so long as I am
not employed by and do not consult with, or become a director of or otherwise engage in any
activities for, such company. The Restricted Period will be extended by the length of any period
during which I am in breach of the terms of this paragraph.

          4. Injunctive Remedies. I acknowledge and agree that the restrictions contained in
this Agreement are reasonably necessary to protect the legitimate business interests of the
Company, and that any violation of any of the restrictions will result in immediate and irreparable
injury to the Company for which monetary damages will not be an adequate remedy. I further
acknowledge and agree that if any such restriction is violated, the Company will be entitled to
immediate relief enjoining such violation (including, without limitation, temporary and permanent
injunctions, a decree for specific performance, and an equitable accounting of earnings, profits,
and other benefits arising from such violation) in any court having jurisdiction over such claim,
without the necessity of showing any actual damage or posting any bond or furnishing any other
security, and that the specific enforcement of the provisions of this Agreement will not diminish
my ability to earn a livelihood or create or impose upon me any undue hardship. I also agree that
any request for such relief by the Company will be in addition to, and without prejudice to, any
claim for monetary damages that the Company may elect to assert.

          5. Severability Provision. I acknowledge and agree that the restrictions imposed upon
me by the terms, conditions, and provisions of this Agreement are fair, reasonable, and reasonably
required for the protection of the Company. In the event that any part of this Agreement is deemed
invalid, illegal, or unenforceable, all other terms, conditions, and provisions of this Agreement
will nevertheless remain in full force and effect. In the event that the provisions of any of
Sections l, 2, or 3 of this Agreement relating to the geographic area of restriction, the length of
restriction or the scope of restriction will be deemed to exceed the maximum area, length or scope
that a court of competent jurisdiction would deem enforceable, said area, length or scope will, for
purposes of this Agreement, be deemed to be the maximum area, length of time or scope that such
court would deem valid and enforceable, and that such

3

 

court has the authority under this Agreement to rewrite (or “blue-pencil”) the restriction(s)
at-issue to achieve this intent.

          6. Non-Waiver. Any waiver by the Company of my breach of any term, condition, or
provision of this Agreement will not operate or be construed as a waiver of the Company’s rights
upon any subsequent breach.

          7. Waiver of Jury Trial. TO THE MAXIMUM EXTENT PERMITTED BY LAW, I HEREBY KNOWINGLY,
VOLUNTARILY, AND INTENTIONALLY WAIVE THE RIGHT TO A TRIAL BY JURY IN CONNECTION WITH ANY LITIGATION
ARISING OUT OF, UNDER, IN CONNECTION WITH, OR IN ANY WAY RELATED TO THIS AGREEMENT. THIS INCLUDES,
WITHOUT LIMITATION, ANY LITIGATION CONCERNING ANY COURSE OF CONDUCT, COURSE OF DEALING, STATEMENT
(WHETHER VERBAL OR WRITTEN), OR ACTION OF THE COMPANY OR ME, OR ANY EXERCISE BY THE COMPANY OR ME
OF OUR RESPECTIVE RIGHTS UNDER THIS AGREEMENT OR IN ANY WAY RELATING TO THIS AGREEMENT. I FURTHER
ACKNOWLEDGE THAT THIS WAIVER IS A MATERIAL INDUCEMENT FOR THE COMPANY TO ISSUE AND ACCEPT THIS
AGREEMENT.

          8. Continuation of Employment. This Agreement does not constitute a contract of
employment or an implied promise to continue my employment or status with the Company; nor does
this agreement affect my rights or the rights of the Company to terminate my employment status at
any time with or without cause (subject to the consequences set forth in the Agreement to which
this Annex is attached).

          9. Governing Law. This Agreement will be construed in accordance with and governed
for all purposes by the laws and public policy of the State of New York, without regard to
principles of conflict of laws.

	 	 	 
	     /s/ William E. Pence
 

William E. Pence

	 	 
	 
	 	 
	     October 1, 2007
 

Date

	 	 

4

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00157-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00157-of-00352.parquet"}]]